These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26075103)

  • 21. The Effects of Histone Deacetylase Inhibition on the Levels of Cerebral Cytokines in an Animal Model of Mania Induced by Dextroamphetamine.
    Valvassori SS; Resende WR; Varela RB; Arent CO; Gava FF; Peterle BR; Dal-Pont GC; Carvalho AF; Andersen ML; Quevedo J
    Mol Neurobiol; 2018 Feb; 55(2):1430-1439. PubMed ID: 28168425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histone deacetylase activity and brain-derived neurotrophic factor (BDNF) levels in a pharmacological model of mania.
    Stertz L; Fries GR; Aguiar BW; Pfaffenseller B; Valvassori SS; Gubert C; Ferreira CL; Moretti M; Ceresér KM; Kauer-Sant'Anna M
    Braz J Psychiatry; 2014; 36(1):39-46. PubMed ID: 24346357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imipramine Can Be Effective on Depressive-Like Behaviors, but Not on Neurotrophic Factor Levels in an Animal Model for Bipolar Disorder Induced by Ouabain.
    Possamai-Della T; Dal-Pont GC; Resende WR; Aguiar-Geraldo JM; Peper-Nascimento J; Quevedo J; Valvassori SS
    Mol Neurobiol; 2022 Dec; 59(12):7170-7181. PubMed ID: 36121567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain creatine kinase activity in an animal model of mania.
    Streck EL; Amboni G; Scaini G; Di-Pietro PB; Rezin GT; Valvassori SS; Luz G; Kapczinski F; Quevedo J
    Life Sci; 2008 Feb; 82(7-8):424-9. PubMed ID: 18191157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Behavioral and neurochemical effects of sodium butyrate in an animal model of mania.
    Moretti M; Valvassori SS; Varela RB; Ferreira CL; Rochi N; Benedet J; Scaini G; Kapczinski F; Streck EL; Zugno AI; Quevedo J
    Behav Pharmacol; 2011 Dec; 22(8):766-72. PubMed ID: 21989497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimanic-like activity of candesartan in mice: Possible involvement of antioxidant, anti-inflammatory and neurotrophic mechanisms.
    de Souza Gomes JA; de Souza GC; Berk M; Cavalcante LM; de Sousa FC; Budni J; de Lucena DF; Quevedo J; Carvalho AF; Macêdo D
    Eur Neuropsychopharmacol; 2015 Nov; 25(11):2086-97. PubMed ID: 26321203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of lithium and valproate on serum and hippocampal neurotrophin-3 levels in an animal model of mania.
    Walz JC; Frey BN; Andreazza AC; Ceresér KM; Cacilhas AA; Valvassori SS; Quevedo J; Kapczinski F
    J Psychiatr Res; 2008 Apr; 42(5):416-21. PubMed ID: 17512948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alpha-lipoic acid alone and combined with clozapine reverses schizophrenia-like symptoms induced by ketamine in mice: Participation of antioxidant, nitrergic and neurotrophic mechanisms.
    Vasconcelos GS; Ximenes NC; de Sousa CN; Oliveira Tde Q; Lima LL; de Lucena DF; Gama CS; Macêdo D; Vasconcelos SM
    Schizophr Res; 2015 Jul; 165(2-3):163-70. PubMed ID: 25937462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resveratrol protects the brain against oxidative damage in a dopaminergic animal model of mania.
    Menegas S; Ferreira CL; Cararo JH; Gava FF; Dal-Pont GC; Gomes ML; Agostini JF; Schuck PF; Scaini G; Andersen ML; Quevedo J; Valvassori SS
    Metab Brain Dis; 2019 Jun; 34(3):941-950. PubMed ID: 30919245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of lithium and valproate on oxidative stress and behavioral changes induced by administration of m-AMPH.
    da-Rosa DD; Valvassori SS; Steckert AV; Ornell F; Ferreira CL; Lopes-Borges J; Varela RB; Dal-Pizzol F; Andersen ML; Quevedo J
    Psychiatry Res; 2012 Aug; 198(3):521-6. PubMed ID: 22429481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carvedilol attenuates neuroleptic-induced orofacial dyskinesia: possible antioxidant mechanisms.
    Naidu PS; Singh A; Kulkarni SK
    Br J Pharmacol; 2002 May; 136(2):193-200. PubMed ID: 12010767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Omega-3 Fatty Acids and Mood Stabilizers Alter Behavioural and Energy Metabolism Parameters in Animals Subjected to an Animal Model of Mania Induced by Fenproporex.
    Cancelier K; Gomes LM; Carvalho-Silva M; Teixeira LJ; Rebelo J; Mota IT; Arent CO; Mariot E; Kist LW; Bogo MR; Quevedo J; Scaini G; Streck EL
    Mol Neurobiol; 2017 Aug; 54(6):3935-3947. PubMed ID: 27246566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coadministration of lithium and celecoxib reverses manic-like behavior and decreases oxidative stress in a dopaminergic model of mania induced in rats.
    Valvassori SS; Tonin PT; Dal-Pont GC; Varela RB; Cararo JH; Garcia AF; Gava FF; Menegas S; Soares JC; Quevedo J
    Transl Psychiatry; 2019 Nov; 9(1):297. PubMed ID: 31723123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of neurotrophic factors in manic-, anxious- and depressive-like behaviors induced by amphetamine sensitization: Implications to the animal model of bipolar disorder.
    Valvassori SS; Mariot E; Varela RB; Bavaresco DV; Dal-Pont GC; Ferreira CL; Andersen ML; Tye SJ; Quevedo J
    J Affect Disord; 2019 Feb; 245():1106-1113. PubMed ID: 30699853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carvedilol protects against glomerulosclerosis in rat remnant kidney without general changes in antioxidant enzyme status. A comparative study of two beta-blocking drugs, carvedilol and propanolol.
    Van den Branden C; Gabriels M; Vamecq J; Vanden Houte K; Verbeelen D
    Nephron; 1997; 77(3):319-24. PubMed ID: 9375827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Na+,K+-ATPase activity in an animal model of mania.
    Zugno AI; Valvassori SS; Scherer EB; Mattos C; Matté C; Ferreira CL; Rezin GT; Wyse AT; Quevedo J; Streck EL
    J Neural Transm (Vienna); 2009 Apr; 116(4):431-6. PubMed ID: 19255820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lithium and valproate modulate antioxidant enzymes and prevent ouabain-induced oxidative damage in an animal model of mania.
    Jornada LK; Valvassori SS; Steckert AV; Moretti M; Mina F; Ferreira CL; Arent CO; Dal-Pizzol F; Quevedo J
    J Psychiatr Res; 2011 Feb; 45(2):162-8. PubMed ID: 20627318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carvedilol prevents severe hypertensive cardiomyopathy and remodeling.
    Barone FC; Campbell WG; Nelson AH; Feuerstein GZ
    J Hypertens; 1998 Jun; 16(6):871-84. PubMed ID: 9663928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GBR 12909 administration as an animal model of bipolar mania: time course of behavioral, brain oxidative alterations and effect of mood stabilizing drugs.
    Queiroz AI; de Araújo MM; da Silva Araújo T; de Souza GC; Cavalcante LM; de Jesus Souza Machado M; de Lucena DF; Quevedo J; Macêdo D
    Metab Brain Dis; 2015 Oct; 30(5):1207-15. PubMed ID: 26073232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of n-acetylcysteine and/or deferoxamine on manic-like behavior and brain oxidative damage in mice submitted to the paradoxal sleep deprivation model of mania.
    Arent CO; Valvassori SS; Steckert AV; Resende WR; Dal-Pont GC; Lopes-Borges J; Amboni RT; Bianchini G; Quevedo J
    J Psychiatr Res; 2015 Jun; 65():71-9. PubMed ID: 25937502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.